Executive summary Essential medicines satisfy the priority health-care needs of the
population. Essential medicines policies are crucial to promoting health and achieving …

Since 2000, access to antiretroviral drugs to treat HIV infection has dramatically increased to
reach more than five million people in developing countries. Essential to this achievement …

Executive summary Despite large gains in health over the past few decades, the distribution
of health risks worldwide remains extremely and unacceptably uneven. Although the health …

The rollout of antiretroviral therapy (ART) significantly reduced human immunodeficiency
virus (HIV)-related morbidity and mortality, but good clinical outcomes depend on access …

Background Indian manufacturers of generic antiretroviral (ARV) medicines facilitated the
rapid scale up of HIV/AIDS treatment in developing countries though provision of low-priced …

Background Tiered pricing-the concept of selling drugs and vaccines in developing
countries at prices systematically lower than in industrialized countries-has received …

Problems with the quality of medicines abound in countries where regulatory and legal
oversight are weak, where medicines are unaffordable to most, and where the official supply …

The US President's Emergency Plan for AIDS Relief (PEPFAR) has shifted from an
emergency response to a sustainable, country-owned response. The process of transition to …

Abstract Background and Objectives The World Health Organization Model List of Essential
Medicines has led to at least 137 national lists. Essential medicines should be grounded in …

Aim To describe the global insulin market. Methods Market intelligence data, United Nations
Commodity Trade Statistics for insulin trade, the International Medical Products Price Guide …